Operational Handbooks

5.1 Recommended TPT regimens

TPT falls broadly into three categories: (i) isoniazid monotherapy for 6 or 9 months (6H or 9H), (ii) rifamycin-based shorter treatment and (iii) Lfx for 6 months (6Lfx) for people exposed to MDR/ RR-TB. Isoniazid preventive treatment (IPT) for 6 months was the mainstay of TPT until recently, for both adults and children, HIV-positive and HIV-negative, and in high and low TB incidence countries. Several systematic reviews have consistently demonstrated the efficacy of IPT in preventing TB disease among people infected with M. tuberculosis.

2.2 Assessing the situation

The epidemiology of TB in each setting and the social and the health-system contexts will inform decisions on a TB screening strategy, including how risk groups are prioritized, which screening approach to choose and whether screening of specific risk groups is feasible. Therefore, before embarking on detailed planning, a baseline assessment of the following features should be undertaken:

6.1.1 Selecting a biological safety cabinet for a TB laboratory

The two types of BSCs described below are best suited for use in moderate-risk laboratories and in high-risk laboratories (TB-containment laboratories).

Class I

This type of BSC provides personal and environmental protection but does not offer product protection. This lack of product protection may contribute to increased contamination rates, especially when preparing and inoculating liquid cultures (see Figure 1).

Class II